Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
|Slideshows|April 13, 2020
When No Facemasks are Available: CDC Options
Author(s)Grace Halsey
When the face masks are gone, how does care for COVID-19 patients continue? The CDC provides 6 work-arounds to protect HCP.
Advertisement
When a supply of face masks has been depleted and reuse of existing items is no longer feasible, the Centers for Disease Control and Prevention (CDC) provides 6 options as work-arounds including limiting patient contact to healthcare professionals (HCP) who have clinically recovered from COVID-19 and excluding from direct patient contact any HCP who are at higher risk for severe illness.Are homemade masks a viable option? Scroll through the slides below for CDC's guidance.
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
3
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
4
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
5